Age-related macular degeneration (AMRD) could be treated by transplanting photoreceptors produced by the directed differentiation of stem cells, thanks to findings published today by Professor Gilbert Bernier of the University of Montreal and its affiliated Maisonneuve-Rosemont Hospital.
ARMD is a common eye problem caused by the loss of cones. Bernier’s team has developed a highly effective in vitro technique for producing light sensitive retina cells from human embryonic stem cells. “Our method has the capacity to differentiate 80% of the stem cells into pure cones,” Professor Gilbert explained. “Within 45 days, the cones that we allowed to grow towards confluence spontaneously formed organised retinal tissue that was 150 microns thick. This has never been achieved before.”
In order to verify the technique, Bernier injected clusters of retinal cells into the eyes of healthy mice. The transplanted photoreceptors migrated naturally within the retina of their host. “Cone transplant represents a therapeutic solution for retinal pathologies caused by the degeneration of photoreceptor cells,” Bernier explained. “To date, it has been difficult to obtain great quantities of human cones.” His discovery offers a way to overcome this problem, offering hope that treatments may be developed for currently non-curable degenerative diseases, like Stargardt disease and ARMD. “Researchers have been trying to achieve this kind of trial for years,” he said. “Thanks to our simple and effective approach, any laboratory in the world will now be able to create masses of photoreceptors. Even if there’s a long way to go before launching clinical trials, this means, in theory, that will be eventually be able to treat countless patients.”
The findings are particularly significant in the light of improving life expectancies and the associated increase in cases of ARMD. ARMD is in fact the greatest cause of blindness amongst people over the age of 50 and affects millions of people worldwide. And as we age, it is more and more difficult to avoid – amongst people over 80, this accelerated aging of the retina affects nearly one in four. People with ARMD gradually lose their perception of colours and details to the point that they can no longer read, write, watch television or even recognize a face.
ARMD is due to the degeneration of the macula, which is the central part of the retina that enables the majority of eyesight. This degeneration is caused by the destruction of the cones and cells in the retinal pigment epithelium (RPE), a tissue that is responsible for the reparation of the visual cells in the retina and for the elimination of cells that are too worn out. However, there is only so much reparation that can be done as we are born with a fixed number of cones. They therefore cannot naturally be replaced. Moreover, as we age, the RPE’s maintenance is less and less effective – waste accumulates, forming deposits. “Differentiating RPE cells is quite easy. But in order to undertake a complete therapy, we need neuronal tissue that links all RPE cells to the cones. That is much more complex to develop,” Bernier explains, noting nonetheless that he believes his research team is up to the challenge.
Bernier has been interested in the genes that code and enable the induction of the retina during embryonic development since completing his PhD in Molecular Biology in 1997. “During my post-doc at the Max-Planck Institute in Germany, I developed the idea that there was a natural molecule that must exist and be capable of forcing embryonic stem cells into becoming cones,” he said. Indeed, bioinformatic analysis led him to predict the existence of a mysterious protein: COCO, a “recombinational” human molecule that is normally expressed within photoreceptors during their development.
In 2001, he launched his laboratory at Maisonneuve-Rosemont Hospital and immediately isolated the molecule. But it took several years of research to demystify the molecular pathways involved in the photoreceptors development mechanism. His latest research shows that in order to create cones, COCO can systematically block all the signalling pathways leading to the differentiation of the other retinal cells in the eye. It’s by uncovering this molecular process that Bernier was able to produce photoreceptors. More specifically, he has produced S-cones, which are photoreceptor prototypes that are found in the most primitive organisms.
Beyond the clinical applications, Professor Bernier’s findings could enable the modelling of human retinal degenerative diseases through the use of induced pluripotent stem cells, offering the possibility of directly testing potential avenues for therapy on the patient’s own tissues.
Read more: Restoring vision with stem cells
The Latest on: Restoring vision with stem cells
via Google News
The Latest on: Restoring vision with stem cells
- Healing spinal cord injuries by reprogramming scar-forming cellson March 5, 2021 at 8:00 am
Researchers at UT Southwestern and Indiana University used genetic engineering to reprogram specific cells called NG2 glia to overproduce the protein Sox2 in mouse models of spinal cord injury. The ...
- Seeking Enlightenment: The Quest To Restore Vision In Humanson March 2, 2021 at 4:00 pm
Whether it’s about navigating a busy city or interacting with the countless screens that fill modern life, coping with reduced or no vision is ... to turn every cell into a stem cell.
- $25 million Hillman grant for Pitt to make the region a vision care hubon March 2, 2021 at 1:36 am
A giant in the field of vision research and treatment, Dr. José-Alain Sahel is building a team of researchers that will rival the best in the world.
- Ocular Surface Reconstruction: Recent Innovations, Surgical Candidate Selection and Postoperative Managementon February 28, 2021 at 4:00 pm
and restore vision. Amniotic membrane and other substrates function as tissue surrogates and substrates for expansion of stem cells. Maximum graft survivability necessitates aggressive and ...
- Life Biosciences Announces Pioneering Research in Nature Describing New Mechanisms for Reversing Age-Related Diseaseon February 18, 2021 at 8:58 am
Life Biosciences, a pioneering life sciences company targeting the biology of aging, has in-licensed intellectual property related to scientific findings recently described in two ...
- Human ESC–derived retinal epithelial cell sheets potentiate rescue of photoreceptor cell loss in rats with retinal degenerationon February 2, 2021 at 4:00 pm
Stem cell–derived RPE cells have shown promise as a cell therapy ... A direct comparison of RPE cell suspensions versus RPE cell sheets without substrate reported similar restoration of vision in a ...
- Paragon Biosciences Launches CiRC Biosciences to Expand Cell and Gene Therapy Platformon February 2, 2021 at 5:17 am
Pre-clinical studies have shown efficacy in blind mice that demonstrated vision restoration ... to manufacturer than using traditional stem cells. Working with Paragon Biosciences to build ...
- Paragon Biosciences Adds CiRC Biosciences to Expand Cell and Gene Therapy Platformon February 2, 2021 at 5:00 am
Paragon Biosciences, a life science innovator that creates, invests in and builds life science companies in biopharmaceuticals, cell and ...
- Remyelinating drug could help restore lost vision in MS patientson February 1, 2021 at 4:00 pm
Previous work by the team showed that IndCl can remyelinate damaged axons, so this time they studied its effects on the optic nerve, and whether that could help restore lost vision. “IndCl has ...
- Developing cures with stem cells and regenerative medicineon August 5, 2019 at 8:55 pm
“Restoring vision in these diseases has become a major focus for our research at Stanford.” Department faculty are now paving the way in battling vision loss through stem cell research focused on ...
via Bing News